Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7304)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Aug 28, 2014 (publication date) through Apr 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: |
Zhang YL, Zhang YC, Han W, Li YM, Wang GN, Yuan S, Wei FX, Wang JF, Jiang JJ, Zhang YW. Effect of |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i32/11287.htm |
| Number | Citing Articles |
| 1 |
Yiming Liu, Xiaodi Zhang, Ting Sun, Junchang Jiang, Ying Li, Mingliang Chen, Zhen Wei, Weiqin Jiang, Linfu Zhou. Knockdown of Golgi phosphoprotein 2 inhibits hepatocellular carcinoma cell proliferation and motility. Oncotarget 2016; 7(16): 21404 doi: 10.18632/oncotarget.7271
|
| 2 |
Rong Yang, Li Qian. Research on Gut Microbiota-Derived Secondary Bile Acids in Cancer Progression. Integrative Cancer Therapies 2022; 21: 153473542211141 doi: 10.1177/15347354221114100
|
| 3 |
Jingjing Tong, Mingjie Yao, Xiuying Mu, Leijie Wang, Xiajie Wen, Xingran Zhai, Xiang Xu, Yu Wang, Jing Chen, Xiangwei Zhai, Chongdan Guan, Fengmin Lu, Jinhua Hu. Relationship between the Level of Serum Golgi Protein 73 and the Risk of Short-term Death in Patients with ALD-ACLF. Journal of Clinical and Translational Hepatology 2022; 10(3): 449 doi: 10.14218/JCTH.2020.00133
|
| 4 |
Ying Yang, Qiang Liu, Hua Zhang, Huarong Zhao, Ruin Mao, Zhipeng Li, Sha Ya, Chunli Jia, Yongxing Bao. Silencing of GP73 inhibits invasion and metastasis via suppression of epithelial-mesenchymal transition in hepatocellular carcinoma. Oncology Reports 2017; 37(2): 1182 doi: 10.3892/or.2017.5351
|
| 5 |
Mingjie Yao, Leijie Wang, Patrick S. C. Leung, Yanmei Li, Shuhong Liu, Lu Wang, Xiaodong Guo, Guangde Zhou, Ying Yan, Guiwen Guan, Xiangmei Chen, Christopher L. Bowlus, Tianhui Liu, Jidong Jia, M. Eric Gershwin, Xiong Ma, Jingmin Zhao, Fengmin Lu. The Clinical Significance of GP73 in Immunologically Mediated Chronic Liver Diseases: Experimental Data and Literature Review. Clinical Reviews in Allergy & Immunology 2018; 54(2): 282 doi: 10.1007/s12016-017-8655-y
|
| 6 |
Yanan Wang, Yu-Jui Yvonne Wan. Golgi protein 73, hepatocellular carcinoma and other types of cancers. Liver Research 2020; 4(4): 161 doi: 10.1016/j.livres.2020.09.003
|
| 7 |
Yanyan Xia, Yuanying Zhang, Mengjiao Shen, Hongpan Xu, Zhiyang Li, Nongyue He. Golgi protein 73 and its diagnostic value in liver diseases. Cell Proliferation 2019; 52(2) doi: 10.1111/cpr.12538
|
| 8 |
Jiuliang Yan, Binghai Zhou, Hui Li, Lei Guo, Qinghai Ye. Recent advances of GOLM1 in hepatocellular carcinoma. Hepatic Oncology 2020; 7(2) doi: 10.2217/hep-2020-0006
|
| 9 |
Nikolaos K Gatselis, Tamás Tornai, Zakera Shums, Kalliopi Zachou, Asterios Saitis, Stella Gabeta, Roger Albesa, Gary L Norman, Mária Papp, George N Dalekos. Golgi protein-73: A biomarker for assessing cirrhosis and prognosis of liver disease patients. World Journal of Gastroenterology 2020; 26(34): 5130-5145 doi: 10.3748/wjg.v26.i34.5130
|